Purchases and Sales Made in Q4 2023 in Indaptus Therapeutics, Inc. (INDP)
This table provides information about the institutional ownership of Indaptus Therapeutics, Inc. (INDP) during Q4 2023. The information is specifically focused on institutions that hold shares of Indaptus Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
16.5KNew |
$28.9K - $45.4K
|
16.5K
$16.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
5.52K+ 2.2% |
$9.65K - $15.2K
|
256K
$251K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
5K+ 20.49% |
$8.75K - $13.8K
|
29.4K
$28.8K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
3.56K+ 2600.0% |
$6.23K - $9.8K
|
3.7K
$3.63K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.66K+ 54.83% |
$2.91K - $4.57K
|
4.7K
$4.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
38New |
$66.5 - $105
|
38
$37.2
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
3New |
$5.25 - $8.25
|
3
$2.94
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 1.96% |
$3.5 - $5.5
|
104
$102
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2+ 28.57% |
$3.5 - $5.5
|
9
$8.82
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-145- 14.09% |
$254 - $399
|
884
$866
|
|
|
Feb 05, 2024
Q4 2023
|
Investment House LLC
Las Vegas, NV |
SELL
|
- |
-412- 0.4% |
$721 - $1.13K
|
102K
$100K
|